BioAffinity Awarded US Federal Supply Schedule Contract for Noninvasive Lung Test
BioAffinity Technologies’ noninvasive lung cancer test is available to Veterans and military personnel for early-stage lung cancer detection.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Lung Cancer |
BioAffinity Technologies’ noninvasive lung cancer test is available to Veterans and military personnel for early-stage lung cancer detection.
Read MorePosted by Andy Lundin | Oct 3, 2024 | Lung Cancer |
A new microchip uses exosome analysis to detect lung cancer from a simple blood draw, enhancing speed and sensitivity in cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostic Analyzers |
The digital PCR system brings precise DNA and RNA quantification to diagnostics for applications like cancer monitoring and liquid biopsies.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Cancer |
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read More